Tirosint and Visual impairment - a phase IV clinical study of FDA data

Summary:

Visual impairment is reported as a side effect among people who take Tirosint (levothyroxine sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Synthroid, and have Depression.

The phase IV clinical study analyzes which people have Visual impairment when taking Tirosint. It is created by eHealthMe based on reports of 4,836 people who have side effects when taking Tirosint from the FDA, and is updated regularly.

What is Tirosint?

Tirosint has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 5,000 Tirosint users. Check the latest studies of Tirosint.

What is Visual impairment?

Visual impairment is found to be associated with 2,256 drugs and 2,336 conditions by eHealthMe. Check the latest studies of Visual impairment.

On Jul, 08, 2026

4,836 people reported to have side effects when taking Tirosint.
Among them, 37 people (0.77%) have Visual impairment.

Among these 37 people:

How long have people been on Tirosint when they have Visual impairment? *

What is the gender of people who have Visual impairment when taking Tirosint? *

female: 96.15 %
male: 3.85 %

What is the age of people who have Visual impairment when taking Tirosint? *

What are other drugs people take besides Tirosint? *

What are other side effects people have besides Visual impairment? *

Headache (pain in head): 10 people, 27.03%
Feeling Abnormal: 10 people, 27.03%
Tremor (trembling or shaking movements in one or more parts of your body): 9 people, 24.32%
Fatigue (feeling of tiredness): 8 people, 21.62%
High Blood Pressure: 7 people, 18.92%
Weakness: 6 people, 16.22%
Dizziness: 6 people, 16.22%
Inflammation: 6 people, 16.22%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 6 people, 16.22%
Weight Decreased: 5 people, 13.51%

What are the existing conditions these people have? *

Depression: 4 people, 10.81%
Vitamin B12 Deficiency: 2 people, 5.41%
Thyroid Diseases: 1 person, 2.70%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.70%
Bipolar Disorder (mood disorder): 1 person, 2.70%
Cardiac Failure: 1 person, 2.70%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 2.70%
Constipation: 1 person, 2.70%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.70%
Drowsiness: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tirosint and have Visual impairment?

- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tirosint:

Tirosint (5,000 reports)

Visual impairment treatments and more:

Visual impairment (128,338 reports)

Browse all side effects of Tirosint:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual impairment:

Visual impairment (2,256 drugs)

Browse all the conditions that are associated with Visual impairment:

Visual impairment (2,336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Tirosint) and Tirosint (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.